ASIC
Harvey Norman, Latitude hit with $55M in penalties in ASIC case
Electronics retailer Harvey Norman and consumer lender Latitude Finance have been socked with a total of $55 million in penalties for a misleading ad campaign seen by millions of Australians.
Restructuring & Insolvency
Jones Day nabs Milbank partner for restructuring team
Jones Day has recruited Milbank's head of APAC restructuring for the global firm's Sydney office to bolster its insolvency practice.
Discrimination
Pauline Hanson loses appeal over ‘piss off back to Pakistan’ tweet
One Nation politician Pauline Hanson has lost her appeal of a ruling that found she breached the Racial Discrimination Act with a tweet that said Greens senator Mehreen Faruqi should “piss off back to Pakistan”.
Financial Services
Credit Suisse wins row over Deloitte reports, Linklaters advice in Greensill case
Two Deloitte reports commissioned by a Swiss law firm for Credit Suisse are protected by legal professional privilege despite access given to financial regulators investigating the collapse of supply chain financier Greensill.
Class Actions
Hotel quarantine class action says only retailers can share $125M deal
A class action over Victoria's hotel quarantine debacle that has settled for $125 million wants to amend the group definition to clarify that non-retail businesses are not part of the case.
Public Corruption
NSW Crime Commission calls for freeze of further Obeid assets
The NSW Crime Commission is seeking to freeze more assets of convicted criminal and former state Labor politician Eddie Obeid, after securing over $30 million in property in March.
Accounting
Lender RND presses new claims against BDO, EY on eve of trial
Lender RND Funding wants to revise its case against BDO Advisory and auditor Ernst & Young over advice given to defunct Adelaide company Gen1 Biotechnology, a week out from trial.
Class Actions
Shine gets extension to serve class actions over stomach acid drugs
Shine Lawyers has won a 12-month extension to serve class actions three against drug companies that sell proton pump inhibitors.
